Skip to main content
$36.77 $2.02 (5.8%)

04:00 PM EDT on 05/20/22

Guardant Health Inc (NASDAQ:GH)

CAPS Rating: 4 out of 5

Current Price $36.77 Mkt Cap $3.7B
Open $35.65 P/E Ratio 0.00
Prev. Close $36.77 Div. (Yield) $0.00 (0.0%)
Daily Range $33.58 - $36.99 Volume 1,626,041
52-Wk Range $27.65 - $133.82 Avg. Daily Vol. 1,530,300

Caps

How do you think NASDAQ:GH will perform against the market?

Add Stock to CAPS Watchlist

All Players

343 Outperform
2 Underperform
 

All-Star Players

42 Outperform
2 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:GH Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

TMFEBCapital (73.12)
Submitted April 22, 2019

Q4 revenue of $32.9 million, up 64%, and FY2018 rev. of $90.6 million, up 82% YoY hints at multibillion opportunity associated with disrupting tissue biopsy genetic discovery. Growing use of liquid biopsy test in solid tumor cancer = FY 2019 revenue… More

CMFTomato (56.67)
Submitted March 20, 2019

High-flyer! Long-term, Guardant Health is doing fascinating things in oncology and there is a tremendous addressable market for their diagnostic offerings, but the story is nearing the top of a hype cycle and with the April 2 lockup expiration… More

NASDAQ:GH VS S&P 500 (SPY)

NASDAQ:GH Summary

Fools bullish on NASDAQ:GH are also bullish on:

Fools bearish on NASDAQ:GH are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about GH.

Recs

0
Member Avatar Car12703 (< 20) Submitted: 1/18/2022 1:19:48 PM : Outperform Start Price: $73.03 NASDAQ:GH Score: -34.73

From Zacks or Fidelity January 2022:
Revenue % Change (Last Qrtr VS. Same Qrtr Prior Year) = 27.1%
Price/Sales (TTM) = 23.0

Recs

0
Member Avatar TMFjimhalley (34.93) Submitted: 4/21/2021 1:31:43 PM : Outperform Start Price: $153.34 NASDAQ:GH Score: -69.53

The company's liquid biopsies are a huge trend and I can see the company possibly being bought out by a larger pharmaceutical company. Plenty of promise and revenue growth but there's risk as well since the company isn't turning a profit.

Recs

0
Member Avatar SadLyzer (< 20) Submitted: 1/29/2021 4:53:48 PM : Outperform Start Price: $155.31 NASDAQ:GH Score: -80.11

Big potential. Telemedicine is more and more important. Could be game changer.

Leaderboard

Find the members with the highest scoring picks in GH.

Score Leader

fusion59102

fusion59102 (76.24) Score: +210.69

The Score Leader is the player with the highest score across all their picks in GH.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
Bigcaps19 89.74 9/16/2019 Underperform 5Y $77.20 -52.38% +29.40% +81.77 0 Comment
mikotian 96.55 5/6/2022 Underperform 5Y $39.66 -7.29% -5.86% +1.43 0 Comment
lancealot 73.60 5/6/2022 Outperform 5Y $47.20 -22.10% -5.60% -16.50 0 Comment
jmaleki333 < 20 10/11/2018 Outperform 5Y $31.26 +17.61% +40.08% -22.47 0 Comment
SwampFox18 52.56 4/29/2022 Outperform 5Y $63.33 -41.94% -7.38% -34.56 0 Comment
Car12703 < 20 1/18/2022 Outperform 5Y $73.03 -49.66% -14.93% -34.73 1 Comment
CoolAsMilesDavis < 20 4/4/2022 Outperform 5Y $74.66 -50.75% -14.88% -35.87 0 Comment
Juvenal 90.90 2/7/2022 Outperform 5Y $73.41 -49.92% -13.45% -36.47 0 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. jerald1103 < 20 4/25/2022 Outperform 3W $66.78 -44.95% -8.25% -36.69 0 Comment
emiliotexidor < 20 4/19/2022 Outperform 5Y $73.68 -50.10% -12.67% -37.43 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for GH.